Product code CIT— Clinical Chemistry

AST

Classification name
Nadh Oxidation/Nad Reduction, Ast/Sgot
Device class
Class 2
Regulation
21 CFR 862.1100
Advisory panel
Clinical Chemistry
Total cleared
139
First cleared
Most recent

Market context for product code CIT

FDA has cleared 139 devices under product code CIT between 1976 and 2010, filed by 81 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

last 15 years

Top applicants under product code CIT

Recent clearances under product code CIT

1–100 of 139

Data sourced from openFDA. This site is unofficial and independent of the FDA.